HAVN Life Sciences Balance Sheet Health
Financial Health criteria checks 3/6
HAVN Life Sciences has a total shareholder equity of CA$837.8K and total debt of CA$26.2K, which brings its debt-to-equity ratio to 3.1%. Its total assets and total liabilities are CA$1.4M and CA$540.4K respectively.
Key information
3.1%
Debt to equity ratio
CA$26.23k
Debt
Interest coverage ratio | n/a |
Cash | CA$13.99k |
Equity | CA$837.82k |
Total liabilities | CA$540.44k |
Total assets | CA$1.38m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HAVN's short term assets (CA$1.4M) exceed its short term liabilities (CA$514.2K).
Long Term Liabilities: HAVN's short term assets (CA$1.4M) exceed its long term liabilities (CA$26.2K).
Debt to Equity History and Analysis
Debt Level: HAVN's net debt to equity ratio (1.5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HAVN's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if HAVN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HAVN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.